Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence
Epidemiological data on psoriasis in Norway are limited. The aim of this study was to provide objective national data on the incidence and prevalence of psoriasis. Patients registered in the Norwegian Prescription Database with a diagnostic code indicating psoriasis vulgaris on prescriptions were in...
Published in: | Acta Dermato-Venereologica |
---|---|
Main Author: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Medical Journals Sweden
2023
|
Subjects: | |
Online Access: | https://doi.org/10.2340/actadv.v103.4591 https://doaj.org/article/d126d206469a4f9fbdcad58857cbdb88 |
id |
ftdoajarticles:oai:doaj.org/article:d126d206469a4f9fbdcad58857cbdb88 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:d126d206469a4f9fbdcad58857cbdb88 2023-06-11T04:15:21+02:00 Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence Silje Michelsen Solberg 2023-04-01T00:00:00Z https://doi.org/10.2340/actadv.v103.4591 https://doaj.org/article/d126d206469a4f9fbdcad58857cbdb88 EN eng Medical Journals Sweden https://medicaljournalssweden.se/actadv/article/view/4591 https://doaj.org/toc/0001-5555 https://doaj.org/toc/1651-2057 doi:10.2340/actadv.v103.4591 0001-5555 1651-2057 https://doaj.org/article/d126d206469a4f9fbdcad58857cbdb88 Acta Dermato-Venereologica, Vol 103 (2023) psoriasis incidence prevalence Norway latitude gradient Dermatology RL1-803 article 2023 ftdoajarticles https://doi.org/10.2340/actadv.v103.4591 2023-04-23T00:33:43Z Epidemiological data on psoriasis in Norway are limited. The aim of this study was to provide objective national data on the incidence and prevalence of psoriasis. Patients registered in the Norwegian Prescription Database with a diagnostic code indicating psoriasis vulgaris on prescriptions were included. During the period 2004 to 2020, 272,725 patients received prescription for psoriasis vulgaris in Norway. During the period 2015 to 2020, 84,432 patients received prescription for psoriasis vulgaris for the first time. In 2020, 71,857 (97.7%) patients received topical, 7,197 (9.8%) conventional systemic and 2,886 (3.9%) biological medication for psoriasis vulgaris. In the period 2015 to 2020, the point prevalence of psoriasis was 3.8–4.6% and the incidence was 0.29–0.25%. Norway is divided into 4 geographical health regions. A latitudinal difference was observed between the 4 regions, highest in Northern Norway. In the incidence population, median age was 47–53 years and males comprised 46–50%. In this study of psoriasis vulgaris, prevalence in Norway was higher than in earlier reports from other countries. There was a small female predominance regarding incidence and prevalence; however, men had more prescriptions for systemic treatment. Prescriptions for psoriasis vulgaris showed a stable level, with a trend of increasing use of biological medication during the study period. Article in Journal/Newspaper Northern Norway Directory of Open Access Journals: DOAJ Articles Norway Acta Dermato-Venereologica 103 adv4591 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
psoriasis incidence prevalence Norway latitude gradient Dermatology RL1-803 |
spellingShingle |
psoriasis incidence prevalence Norway latitude gradient Dermatology RL1-803 Silje Michelsen Solberg Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
topic_facet |
psoriasis incidence prevalence Norway latitude gradient Dermatology RL1-803 |
description |
Epidemiological data on psoriasis in Norway are limited. The aim of this study was to provide objective national data on the incidence and prevalence of psoriasis. Patients registered in the Norwegian Prescription Database with a diagnostic code indicating psoriasis vulgaris on prescriptions were included. During the period 2004 to 2020, 272,725 patients received prescription for psoriasis vulgaris in Norway. During the period 2015 to 2020, 84,432 patients received prescription for psoriasis vulgaris for the first time. In 2020, 71,857 (97.7%) patients received topical, 7,197 (9.8%) conventional systemic and 2,886 (3.9%) biological medication for psoriasis vulgaris. In the period 2015 to 2020, the point prevalence of psoriasis was 3.8–4.6% and the incidence was 0.29–0.25%. Norway is divided into 4 geographical health regions. A latitudinal difference was observed between the 4 regions, highest in Northern Norway. In the incidence population, median age was 47–53 years and males comprised 46–50%. In this study of psoriasis vulgaris, prevalence in Norway was higher than in earlier reports from other countries. There was a small female predominance regarding incidence and prevalence; however, men had more prescriptions for systemic treatment. Prescriptions for psoriasis vulgaris showed a stable level, with a trend of increasing use of biological medication during the study period. |
format |
Article in Journal/Newspaper |
author |
Silje Michelsen Solberg |
author_facet |
Silje Michelsen Solberg |
author_sort |
Silje Michelsen Solberg |
title |
Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
title_short |
Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
title_full |
Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
title_fullStr |
Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
title_full_unstemmed |
Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence |
title_sort |
psoriasis in norway: a prescription-based registry study of incidence and prevalence |
publisher |
Medical Journals Sweden |
publishDate |
2023 |
url |
https://doi.org/10.2340/actadv.v103.4591 https://doaj.org/article/d126d206469a4f9fbdcad58857cbdb88 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Northern Norway |
genre_facet |
Northern Norway |
op_source |
Acta Dermato-Venereologica, Vol 103 (2023) |
op_relation |
https://medicaljournalssweden.se/actadv/article/view/4591 https://doaj.org/toc/0001-5555 https://doaj.org/toc/1651-2057 doi:10.2340/actadv.v103.4591 0001-5555 1651-2057 https://doaj.org/article/d126d206469a4f9fbdcad58857cbdb88 |
op_doi |
https://doi.org/10.2340/actadv.v103.4591 |
container_title |
Acta Dermato-Venereologica |
container_volume |
103 |
container_start_page |
adv4591 |
_version_ |
1768372097080360960 |